SCP-2657
Euclid
~
medium confidence
SCP-2657
Expected annual
$2.8M
One-time setup
$4.5M
Annual recurring
$2.7M
Personnel
14
Initial capital costs to build a compliant containment cell, lab, and initial R&D (notably antivenom development) are substantial (~$4.5M one-time). Main recurring drivers are staff wages (security, researchers, medical, monitoring) and long-term R&D/contingency, yielding annual costs of roughly $2.68M.
One-Time Capital Costs
Total: $4.5M
Annual Recurring Costs
Total: $2.7M/yr
Cost Scenarios
📊
Baseline
(baseline)
$2.7M/yr
Normal year with no major incidents; routine operations, maintenance, monthly cleanings, and ongoing research.
no_incident
routine_operations
🚨
Minor Incident
$2.7M/yr
Small containment breach or personnel envenomation requiring medical response and modest repairs.
small_breach
minor_injury
localized_equipment_failure
🚨
Major Breach
$4.2M/yr
Significant containment failure, public exposure, mass damage or large-scale response required.
containment_breach
public_exposure
mass_escape
🚨
Research Breakthrough Requiring Scale Up
$3.7M/yr
Discovery (e.g., viable antivenom candidate or reproduction event) that triggers rapid scale-up of R&D and manufacturing.
antivenom_success
reproduction_spike
need_for_scale-up
Personnel
14 total
| Role | Count | Notes |
|---|---|---|
| Security Officer / MTF Agent | 8 | [#16] Dedicated guards and rapid-response team (6–12 assumed; staffing and overtime budget included in staff_wages). |
| Research Scientist | 3 | [#21] Arachnologists/ethologists/xenobiologists (2–4 researchers assumed; salaries included in staff_wages). |
| Data Scientist / Monitoring Technician | 2 | [#22] Monitoring personnel and data scientists for 24/7 analytics and model maintenance. |
| Medical Officer | 1 | [#14] On-call physician/medical responder with expertise in neurotoxic envenomation (partial FTE/contract included in staff_wages). |
Confidence Notes
Many line items are well-specified (containment cell, HVAC, staffing), so base recurring and capital estimates are reasonable; largest uncertainty is antivenom R&D scale and breach probabilities, which can change multi-year budgets substantially.